Skip to content

11 results for "Meta-analysis: What did research on Anxiety find in March 2026?"

A Brief Intervention for the Treatment of Anxiety in Pregnancy: A Pilot Randomized Controlled Trial (The TAP Study).

Psychotherapy and Psychosomatics March 30, 2026 Sophie Grigoriadis, Neeti Sharma, Cindy-Lee Dennis et al.

Anxiety during pregnancy affects 1 in 4 pregnancies and is often comorbid with other mental health disorders. Early intervention is crucial to avoid persistent mental health issues and adverse obstetrical, neonatal and child outcomes. Traditional mindfulness-based cognitive therapy is effective, but its uptake is limited by its high resource intensity for patients and healthcare services. This...

An Umbrella Review of Meta-analyses of School-Based Mindfulness Based Interventions (MBIs)

Mindfulness March 18, 2026 Sinead Grennan, Annie O’Dowd, Conal Twomey et al.

Abstract Objectives This umbrella review synthesised evidence from meta-analyses of school-based mindfulness-based interventions (MBIs) to evaluate effects on wellbeing, mindfulness, depression and anxiety in children and adolescents. Method Searches were conducted in PubMed, PsycINFO, CINAHL, ERIC and Cochrane databases, with the timeframe for the search being 2000 to end 2024. Eligibility...

Feasibility and Acceptability of Transcendental Meditation for Indian Healthcare Professionals in a Tertiary Care Hospital: A Pilot Randomized Controlled Feasibility Trial

Cureus March 15, 2026 Shruti Niraj, G Niraj, Rajesh Naithani 1 citation

Healthcare professionals in India are vulnerable to experiencing a high level of burnout, which has consequences for individuals and organizations. This prospective pilot randomized controlled feasibility study examined, for the first time, the feasibility and acceptability of practicing the Transcendental Meditation (TM) technique among healthcare professionals in India. A total of 76...

Examining the implementation of a mindfulness-based intervention for anxiety: A mixed-method, single-case study investigation

Klinik Psikoloji Dergisi March 10, 2026 Aysun Parlar-yazıcı, Alyson Norman, Alison M. Bacon

This single-case study examines the impact of a 6-week Mindfulness-Based Intervention (MBI) on an individual experiencing anxiety, with a particular focus on intolerance of uncertainty (IU). A mixed-methods approach was used, combining quantitative measures with qualitative data from session notes, interviews, and participant feedback. Quantitative findings indicated reductions in stress...

Age moderates the relationship between psychedelics use and mental health in naturalistic settings

Research Square March 10, 2026 Giammarco di Gregorio, Sophia Basset, Harjot Manmohan et al.

Abstract Depression and anxiety affect one in five adults, with age affecting prevalence. While clinical trials suggest classic psychedelics (e.g., psilocybin, LSD) and non-classic psychedelics (e.g., MDMA, ketamine) may alleviate these symptoms, it remains unclear how these relationships function in naturalistic settings or how they vary across the lifespan. We conducted a cross-sectional...

Exploring associations between connectedness and death anxiety following a psychedelic experience

Journal of Psychedelic Studies March 9, 2026 Noah N T Barr, Briony Larance, Matthew J. Schweickle et al.

Abstract Background and aims Increased connectedness has been proposed as one mechanism through which psychedelics might reduce death anxiety. This study examined whether changes in connectedness—across intrapersonal, interpersonal, and transpersonal domains—were associated with changes in death anxiety following a significant psychedelic experience. Methods A retrospective cross-sectional...

Confronting mortality: A meta-analysis and systematic review of psychedelic experiences and death anxiety

Journal of Psychopharmacology March 9, 2026 Alicia Cohorst, Petri Kajonius

This meta-analysis and systematic review examined the effects of psychedelic substances on death anxiety, specifically evaluating whether psychedelic experiences are associated with statistically significant reductions in death anxiety. A systematic search identified 8 studies suitable for meta-analysis and 10 additional studies for systematic review. Using a random-effects model, the...

Effective doses of esketamine oral or esketamine intranasal for the prevention of preoperative anxiety in pediatric patients: A randomized double-blind dose-finding trial

Medicine March 6, 2026 Hongfei Xiong, Yingxue Xu, Jiayi Liu et al.

This study demonstrates the efficacy of single-dose esketamine regimens, administered orally (ED95: 8.2125 mg/kg; 95% CI: 7.4250-8.4597 mg/kg) and intranasally (ED95: 2.1770 mg/kg; 95% CI: 2.0952-2.1958 mg/kg), in mitigating preoperative anxiety within a pediatric population. These findings highlight the safety and efficacy of esketamine for this patient group.

Examining the Effectiveness of Breathwork to Improve Resilience and Psychological Wellbeing While Reducing Anxiety, Depression, Stress, and Insomnia in Paramedicine Students: A Single‐Blind Randomised Controlled Trial

Stress and Health March 5, 2026 A. G. Little, Matthew J. Stainer, Alex Sandy MacQuarrie et al. 1 citation

Paramedicine students experience disproportionately high rates of anxiety, depression, stress, and insomnia compared to the general population, placing them at risk of post-traumatic stress disorder and long-term psychological distress. Breathwork has emerged as a promising self-regulation intervention that may enhance resilience and wellbeing while reducing symptoms of mental illness. This...

A repeated low-dose regimen of MDMA has transient next-day effects on locomotor activity, anxiety-like behavior, and brain serotonin levels, with no effect on anhedonia-like behavior, in both female and male rats

Psychopharmacology March 4, 2026 Ava M. Mac, Srinivasu Kallakuri, Alixandria T. Mascarin et al.

MDMA (3–4 methylenedioxymethamphetamine) assisted psychotherapy has gained considerable attention as a potential adjuvant therapy for post-traumatic stress disorder (PTSD). Reports of the nonmedical use of MDMA suggest its adverse effects may include anxiety and anhedonia. However, the time course of these signs and symptoms and the potential alterations in neurotransmitter levels that may...